News
Your contact
Gabriele Klingner
Communications & Marketing Lead
Christiane Proll
PR & Social Media Manager
News and articles from BioM about and for the Bavarian biotechnology industry.
-
Bavaria’s biotech industry continues to grow: Record funding and start-up boom despite a challenging environment16.06.2026Bavaria’s biotech industry continues to grow: Record funding and start-up boom despite a challenging environmentBioM publishes annual report „Biotech in Bavaria 2025/26 – Where champions grow“ More than EUR 930 million in funding and financing raised by Bavarian biopharma companiesSlight increase to… -
HMNC Brain Health secures $50 million and enters into a strategic partnership with MEDICE15.06.2026HMNC Brain Health secures $50 million and enters into a strategic partnership with MEDICEHMNC Brain Health has successfully completed the first closing of its $50 million Series B funding round. The clinical neurobiotechnology company plans to use the capital to advance the… -
CollimateHealth sichert sich überzeichnete Seed-Finanzierung in Höhe von 6 Millionen Euro für klinisch skalierbare Mikrostrahlentherapie für Krebspatient:innen12.06.2026CollimateHealth sichert sich überzeichnete Seed-Finanzierung in Höhe von 6 Millionen Euro für klinisch skalierbare Mikrostrahlentherapie für Krebspatient:innenDas Münchner Unternehmen CollimateHealth hat eine überzeichnete Seed-Finanzierungsrunde in Höhe von 6 Millionen Euro abgeschlossen, um seine klinisch skalierbare Mikrostrahlentherapie… -
EY German Biotechonoly Report 2026: Funding down slightly – early-stage funding a cause for concern10.06.2026EY German Biotechonoly Report 2026: Funding down slightly – early-stage funding a cause for concernThe German biotechnology sector raised a total of EUR 1.8 billion in capital in 2025. This represents a five percent decline compared to the previous year. At the same time, the situation for… -
LMU opens new building for diagnostics and translational research10.06.2026LMU opens new building for diagnostics and translational researchTranslating excellent research findings from microbiology and virology into clinical diagnostics is an important step toward faster, more effective treatment and prevention of disease spread.… -
BIO-Europe 2025: Early bird rate expires on 1 July - Get the 12% Bio<sup>M</sup> discount now!10.06.2026BIO-Europe 2025: Early bird rate expires on 1 July - Get the 12% BioM discount now!BIO-Europe will take place from 9-11 November 2026 in Cologne (Germany). As the leading partnering conference in Europe, BIO-Europe brings together almost 8,000 visitors from over 60… -
SPRIND “Orbital Bioworks” Challenge08.06.2026SPRIND “Orbital Bioworks” ChallengeSPRIND – Federal Agency for Breakthrough Innovation has launched the new “Orbital Bioworks” challenge to support commercially viable biotechnology applications in microgravity. The program is… -
NUCLIDIUM expands its Series B extension to EUR 115 million27.05.2026NUCLIDIUM expands its Series B extension to EUR 115 millionThe radiopharmaceutical company NUCLIDIUM AG has raised an additional EUR 28.4 million in its Series B financing round. The company plans to use the capital to advance the clinical… -
Two new centers for Infectious Disease research in Bavaria19.05.2026Two new centers for Infectious Disease research in BavariaWith the ceremonial inauguration of the Center for Infection Prevention (ZIP) in Freising-Weihenstephan and the opening of the Bavarian Center for Preventive Infection Medicine (BZI) in… -
Munich-based Sedivention secures €2.9 million seed funding for ambulatory obesity therapy12.05.2026Munich-based Sedivention secures €2.9 million seed funding for ambulatory obesity therapyMedTech startup Sedivention has closed a €2.9 million seed financing round. The round was led by bmp Ventures with the IBG funds. Additional investors include the strategic investment arm of…